Readers discuss an essay about whether it is a disease and how it should be diagnosed. Also: Fear in schools; natural ...

In this detailed exploration, we will delve into a comparative analysis of two such supplements that have been gathering ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

The trial investigated the efficacy and safety of a once-daily 10-mg, 20-mg, and 50-mg dose of monlunabant vs. placebo on body weight after 16 weeks in 243 people with obesity and metabolic syndrome.

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Acadia Pharmaceuticals Inc. today announced that on September 23, 2024, the Board of Directors granted Catherine Owen Adams, Acadia's new Chief Executive Officer, a one-time sign-on equity award of (i ...

Finding free dietitian CEUs is not an easy task, so we did the job for... The post Free Dietitian CEUs appeared first on For ...

Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

The best way to experience the third age is to joyfully accept its arrival and indulge in all the magical experiences it has ...